Events
Irritable bowel syndrom (IBS): How to help my patients with this chronic incapacitating condition?
Replay is available exclusively to members
Create a free account or log inIrritable bowel syndrom (IBS): How to help my patients with this chronic incapacitating condition?
IBS is a chronic condition that affects 10 % of the global population in 2021. Although not severe, it can deeply and durably alter the quality of life of patients. Lots of progresses have been made in the diagnosis and the management of this pathology but the mechanisms triggering this syndrome and its consequences on the lives of patients are still misunderstood. In this Biocodex webinar, three international experts in IBS field give practical tools to help physicians in their daily practice of IBS patients management.
Irritable bowel syndrom (IBS): How to help my patients with this chronic incapacitating condition?
IBS is a chronic condition that affects 10 % of the global population in 2021. Although not severe, it can deeply and durably alter the quality of life of patients. Lots of progresses have been made in the diagnosis and the management of this pathology but the mechanisms triggering this syndrome and its consequences on the lives of patients are still misunderstood. In this Biocodex webinar, three international experts in IBS field give practical tools to help physicians in their daily practice of IBS patients management.
Program
The aim of this 90 minutes webinar is to give healthcare professionals the tools to support patients in their daily life and relieve them from this chronic condition.
Prof. Simrén starts the session by introducing IBS definition, pathophysiology, prevalence and diagnosis (15’ talk).
Then Prof. Sabaté focuses his presentation on the potential impact of stress as a triggering factor of IBS, mainly in the context of Covid-19 pandemic (15’ talk).
Finally, Prof. Quigley talks about the role of probiotics, more precisely Bifidobacterium longum 35624, in the management of IBS (15’ talk).
The webinar ends with a 30 minutes Q/A session to the experts.
About the speakers
Prof. Eamonn M.M. Quigley
Chief of gastroenterology and hepatology, Houston Methodist Hospital (Houston, USA)
Prof. Eamonn Quigley is Chief of the Division of Gastroenterology and Hepatology and Professor of Medicine at the Institute for Academic Medicine at Houston Methodist Hospital (Houston, USA). He is internationally known for his research on gastrointestinal motility disorders, primarily Irritable Bowel Syndrome (IBS); functional gastrointestinal disease; GastroEsophageal Reflux Disease (GERD); neurogastroenterology; the role of gut microbiota and probiotics in health and disease.
Prof. Jean-Marc Sabaté
MD, PhD, Consultant in the gastroenterology department, Avicenne Hospital, APHP (Bobigny, France)
Prof. Jean-Marc Sabaté is working as Consultant in the Department of Gastroenterology, Avicenne University Hospital, Bobigny, France, and is Professor in Gastroenterology at the Sorbonne Paris Nord University. Since 2002, he pursues his research in the Intestinal Bowel Syndrome (IBS) field at the INSERM unit U-987 « Physiopathology and clinical pharmacology of pain » (Ambroise Paré Hospital, France). He is the co-founder and President of the association APSSII (Association of patients suffering from intestinal bowel syndrome).
Prof. Magnus Simrén
Professor of gastroenterology, University of Gothenburg (Gothenburg, Sweden)
Magnus Simrén is Professor of Gastroenterology at the University of Gothenburg and Senior Consultant at the Sahlgrenska University Hospital, Gothenburg, Sweden. His clinical and research focus is on functional gastrointestinal disorders with a particular interest in diet and gut microbiota. He is also currently the Secretary General of United European Gastroenterology.
Interview, digest, … and plenty of resources are available exclusively to members
Create a free account or log in
